Thomas McHugh Net Worth & Insider Trades
Thomas McHugh - Chief Financial Officer, Avadel Pharmaceuticals Plc
What is Thomas McHugh's Net Worth?
The current estimated net worth of Avadel Pharmaceuticals Plc's Chief Financial Officer, Thomas McHugh, is estimated to be about $231.1K . Thomas McHugh owns about 76,500 units of Avadel Pharmaceuticals Plc common stock. In the last 2 years at Avadel Pharmaceuticals Plc, Thomas McHugh has sold an estimated value of $0 worth.
What is Thomas McHugh's Past Insider Trading?
Thomas McHugh's largest purchase order was 50,000 units , worth over $106.89K on May 31, 2022. In total, Thomas McHugh has made about 7 transactions over 2 years of their time at Avadel Pharmaceuticals Plc. Thomas McHugh usually trades in September and December, with the busiest year in 2020. The most recent transaction was a purchase order of 5,000 units , worth over $39K on November 30, 2022.
THOMAS MCHUGH
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Thomas McHugh's Salary in 2020?
As Chief Financial Officer of Avadel Pharmaceuticals Plc, Thomas McHugh has a total base salary of $385,000 . The vast majority of their compensation came in the form of option awards of $898,678 , other earnings, plans or compensations of $1,479,878 , and other compensation of $11,400 .
What is Thomas McHugh's' Mailing Address?
- Mailing address is 2280 Schuetz Road St. Louis MO 63146 MO
Avadel Pharmaceuticals Plc Executive Compensation
Name |
Year
|
Salary
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Other Earnings Plans or Compensations
|
|---|---|---|---|---|---|---|---|
| Gregory J. Divis | 2020 | $520,000 | - | $2,246,694 | $3,143,694 | $23,400 | $3,143,694 |
| Gregory J. Divis | 2019 | $472,292 | $33,300 | $485,010 | $1,436,262 | $23,316 | $1,436,262 |
| Gregory J. Divis | 2018 | $417,178 | - | $198,500 | $685,428 | $23,000 | $685,428 |
| Thomas S. McHugh | 2020 | $385,000 | - | $898,678 | $1,479,878 | $11,400 | $1,479,878 |
| Thomas S. McHugh | 2019 | $33,688 | - | $469,600 | $503,288 | - | $503,288 |
| Jordan S. Dubow | 2020 | $368,756 | - | $254,604 | $859,740 | $236,381 | $859,740 |
| Jordan S. Dubow | 2019 | $293,296 | - | $273,258 | $743,224 | $10,282 | $743,224 |
| Phillandas T. Thompson | 2020 | $310,594 | - | - | $850,652 | $417,041 | $850,652 |
| Phillandas T. Thompson | 2019 | $383,400 | $33,300 | $103,250 | $698,157 | $21,780 | $698,157 |
| Phillandas T. Thompson | 2018 | $365,968 | - | - | $450,378 | $20,000 | $450,378 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1012477/000110465921059020/tm212548-2_def14a.htm
What are Avadel Pharmaceuticals Plc's Past Insider Trades?
Avadel Pharmaceuticals Plc's most recent insider trade came on December 28, 2022 by Linda Palczuk who bought 2,000 units worth $14.4K . In the last 5 years, insiders at Avadel Pharmaceuticals Plc have sold an estimated value of $6.27M and bought an estimated value of $5.32M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Eric Ende, Director, Craig R Stapleton, Director, and Michael Geoffrey Glass, Director .
AVADEL PHARMACEUTICALS PLC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||